Putting Susceptibility Testing Results for Gram Negative Organisms into Practice

Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include the latest recommendations in the 2022 CLSI standards for antimicrobial susceptibility testing and reporting and will identify new opportunities for collaboration between stewardship and the microbiology laboratory.

Agenda

Upon completion of this activity, participants should be able to:

1. Discuss the latest recommendations in the 2022 CLSI standards for antimicrobial susceptibility testing and reporting.
2. Describe ways in which stewardship teams can utilize susceptibility testing results to optimize patient outcomes.
3. Identify new opportunities for collaboration between stewardship and the microbiology laboratory.

Events

Date / Time
Event Details

Faculty

Faculty
Samuel L. Aitken, PharmD, MPH, BCIDP

Adjunct Clinical Professor
University of Michigan College of Pharmacy
Clinical Pharmacist Specialist, Infectious Diseases
Department of Pharmacy
Michigan Medicine
Ann Arbor, Michigan

Faculty
Tanis Dingle, PhD, FCCM, D(ABMM)

Clinical Associate Professor
Department of Pathology and Laboratory Medicine
University of Calgary
Clinical Microbiologist
Public Health Laboratory
Alberta Precision Laboratories
Calgary, Alberta, Canada

Program Overview
Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include the latest recommendations in the 2022 CLSI standards for antimicrobial susceptibility testing and reporting and will identify new opportunities for collaboration between stewardship and the microbiology laboratory.

Goal Statement
The goal of this program is to improve the knowledge of learners in applying antimicrobial susceptibility testing results to optimize patient outcomes.

Target Audience
The target audience for this activity is pharmacists and laboratory professionals.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the latest recommendations in the 2022 CLSI standards for antimicrobial susceptibility testing and reporting.
  • Describe ways in which stewardship teams can utilize susceptibility testing results to optimize patient outcomes.
  • Identify new opportunities for collaboration between stewardship and the microbiology laboratory.

Accreditation

CE Accreditation

Pharmacists

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-199-L01-P has been assigned to this live application-based activity (initial release date 7/14/2022). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.clinicaloptions.com, and proof of completion will be posted in NABP CPE Monitor profiles.

PACE
Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E Program.

Disclosure
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.